Montelukast Oral Suspension (Anhydrous)
Montelukast is a compounded formulation containing Montelukast, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Montelukast sodium is a leukotriene receptor antagonist utilized in veterinary medicine for its ability to influence localized inflammatory responses. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for patients presented with respiratory health challenges or environmental sensitivities. Your veterinarian will determine the clinical appropriateness of this medication based on your pet's diagnostic findings.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is considered to influence the physiological response to leukotrienes, which are mediators involved in airway constriction and inflammation. Commonly observed effects are typically rare but may include localized digestive changes such as vomiting or behavioral shifts like temporary restlessness. Owners should monitor for any unusual changes in energy or appetite and contact their veterinarian promptly. It is typically evaluated carefully in patients with known severe hepatic impairment.
Yes. Montelukast is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab verifies all legal and professional requirements before preparing any medication.
Yes. Mixlab specializes in compounding montelukast into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to support easier administration for your pet.
Veterinarians discuss montelukast because it is considered to influence the receptors that may contribute to airways tightening and swelling in response to triggers. This provides a method for addressing respiratory comfort during recovery.
No. Montelukast is a leukotriene receptor antagonist, which is a different class of medication than corticosteroids. Your veterinarian will determine if it is the right approach for your pet's specific inflammatory needs.
You should monitor for observational signs like easier breathing and a decrease in coughing or sneezing. Your veterinarian will provide a specific monitoring schedule for your pet's management plan.
